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Abstract
Background: Severe respiratory syncytial virus infection (RSV) during infancy has been shown to be
a major risk factor for the development of subsequent wheeze. However, the reasons for this link
remain unclear. The objective of this research was to determine the consequences of early
exposure to RSV and allergen in the development of subsequent airway hyperreactivity (AHR)
using a developmental time point in the mouse that parallels that of the human neonate.
Methods: Weanling mice were sensitized and challenged with ovalbumin (Ova) and/or infected
with RSV. Eight days after the last allergen challenge, various pathophysiological endpoints were
examined.
Results: AHR in response to methacholine was enhanced only in weanling mice exposed to Ova
and subsequently infected with RSV. The increase in AHR appeared to be unrelated to pulmonary
RSV titer. Total bronchoalveolar lavage cellularity in these mice increased approximately two-fold
relative to Ova alone and was attributable to increases in eosinophil and lymphocyte numbers.
Enhanced pulmonary pathologies including persistent mucus production and subepithelial fibrosis
were observed. Interestingly, these data correlated with transient increases in TNF-α, IFN-γ, IL-5,
and IL-2.
Conclusion:  The observed changes in pulmonary structure may provide an explanation for
epidemiological data suggesting that early exposure to allergens and RSV have long-term
physiological consequences. Furthermore, the data presented here highlight the importance of
preventative strategies against RSV infection of atopic individuals during neonatal development.
Introduction
Several experimental studies have shown a synergistic
interaction between respiratory viral infections and aller-
gic inflammation that exacerbate asthma [1-3]. RSV is the
most common respiratory pathogen during infancy, and
the majority of children worldwide have been infected
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with it by 2 years of age[4]. Several retrospective studies
have suggested a link between RSV lower respiratory tract
infections in infancy and the later development of asthma
[5-10]. In a more recent study conducted by Sigurs and
colleagues using a cohort of 140 children (47 of whom
were hospitalized for RSV bronchiolitis during the first
year of life and a control population of 93 infants with no
history of RSV infection), it was found that by 7 years of
age 30% of the children in the RSV group had experienced
recurrent physician-diagnosed "wheeze" (ie, asthma) as
compared to 3% of the control group[11]. Multivariant
analyses further demonstrated that the greatest risk factor
for asthma was RSV bronchiolitis independent of a family
history of atopy. Moreover, the Tucson Children's Respi-
ratory Study demonstrated that even children with mild
RSV infections were 4 times more likely to have recurrent
wheeze by 6 years of age[12]. Cumulatively, the data sug-
gest that RSV bronchiolitis in infancy is associated with an
increased risk of wheeze, which may persist for several
years and is not adequately explained by a family history
of atopy. Whether RSV directly contributes to the develop-
ment of asthma remains unclear.
A recent study using an animal model of RSV infection
demonstrated that "infections in early life play an impor-
tant role" in shaping the secondary immune response to
antigen leading to long-term consequences for the
host[13]. In this study, Culley and colleagues showed that
the age of initial infection played a significant role in the
secondary response of these same animals to rechallenge
with RSV at 12 weeks of age. Interestingly, if the mice were
initially infected at 1 – 7 days of age, then their immune
response to rechallenge at 12 weeks of age was character-
ized by enhanced bronchoalveolar lavage (BAL) cellular-
ity including increased eosinophil and neutrophil
numbers, increased CD8+ T cell numbers, and increased
CD4+ T cell production of intracellular IL-4. The data
seemed to indicate that a CD4+ response was important
in creating the immune memory response of the neonatal
mice to RSV, while a CD8+ response seemed important in
the older animals (age 4 – 8 wks). Furthermore, these data
suggested that the Th2 skewing of the immune response
was likely to be important in eliciting disease pathogene-
sis. Although this work was seminal in demonstrating the
importance of timing (7 d vs. 4 wks) of the initial infec-
tion on the subsequent T cell responses, it did not link
these events with enhanced pulmonary dysfunction or
demonstrate the prolonged contribution of these T cell
responses to pathophysiological events involved in airway
remodeling associated with asthma. Recently, Dakhama
and colleagues[14] demonstrated that indeed timing of
initial infection was a critical factor in determining the air-
way response to subsequent RSV infection. However,
other risk factors for the development of pulmonary
inflammation and wheeze (i.e., asthma) in humans exist
and the enhancement of pulmonary inflammation by RSV
may be dependent on the individual's atopic background
and current exposure to allergens or other environmental
factors.
Our hypothesis was that early exposure to RSV and aller-
gen act synergistically to illicit inflammatory responses
and long-term functional changes in the developing lung.
We further hypothesized that these changes were the
result of changes in airway structure (i.e., remodeling) and
therefore, would compromise adult lung function. In the
present study, weanling mice were exposed to RSV and/or
ovalbumin (Ova) to examine the effect of early exposures
on pulmonary pathophysiology. We report that weanling
mice infected with RSV then exposed, Ova fail to develop
airway hyperreactivity (AHR) or long-term pathophysio-
logic changes, while weanling mice exposed first to Ova
then infected with RSV developed increased AHR and
long-term pulmonary pathologies. This increase in AHR
was accompanied by pulmonary inflammation due to
increased eosinophil and lymphocyte cell numbers,
mucus cell hypertrophy, and enhanced mucus produc-
tion. Intriguingly, the mice also exhibited signs of airway
remodeling including subepithelial fibrosis. The observed
remodeling events were correlated with increased levels of
various cytokines including TNF-α, IFN-γ, IL-5, and IL-2.
Collectively, these data demonstrate that RSV infections,
when combined with an allergic predisposition, can have
long-term consequences for the lung and may contribute
to the development of inflammatory disease states, such
as asthma.
Methods
Mice
BALB/cJ mice, 6 – 10 weeks of age, were purchased from
Jackson Labs and were maintained in ventilated micro-
isolator cages housed in a specific pathogen-free animal
facility. Sentinel mice within this animal colony were neg-
ative for antibodies to viral and other known mouse path-
ogens. All animal protocols were prepared in accordance
with the Guide for the Care and Use of Laboratory Ani-
mals (National Research Council, 1996) and approved by
the Institutional Animal Care and Use Committees at
Mayo Clinic Arizona and Louisiana State University.
Viral Preparation and Infection of Mice with RSV
RSV strain A2 (a kind gift of Dr. Barney Graham; NIH) was
originally provided by Dr. R Chanock (NIH) and has since
been maintained in culture by passage in HEp-2 cells.
Master stocks and working stocks of virus were prepared
as described elsewhere[15]. Prior to infection all mice
were anesthetized with 3% isoflurane. Mice were subse-
quently infected intratracheally (i.t.) with RSV (104
TCID50/g body weight) or mock infected (i.e., culture
media alone) at 21 or 47 days of age (Figure 1). Four daysRespiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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post-infection viral titer was determined using the TCID50
method of Spearman-Kärber[16,17].
Ovalbumin Sensitization and Challenge Protocol
Mice were sensitized and challenged with chicken ovalbu-
min (Ova; crude grade IV; Sigma, St. Louis, MO) as previ-
ously described [18]. Mice were sensitized with an
intraperitoneal (i.p.) injection of 0.1 ml (20 µg) Ova com-
plexed with 2 mg Imject Alum (Al [OH]3/Mg [OH]2;
Pierce, Rockford, IL) on protocol days 0 and 14 (Figure 1).
Mice were subsequently challenged with an aerosol gener-
ated from an Ova solution (1% Ova w/v in saline) for 20
minutes on protocol days 24, 25, and 26 using an ultra-
sonic nebulizer (DeVilbiss, Somerset, PA). Control ani-
mals were injected i.p. with saline on days 0 and 14 and
challenged with aerosolized saline on protocol days 24,
25, and 26 as described above. The mice were assessed for
pulmonary cellular infiltrates, histopathologies, and lung
function on protocol day 34.
Study Protocol
The study protocol is outlined in Figure 1. The mice were
divided into six groups. The SAL group was mock-allergen
sensitized and challenged. The OVA group was Ova sensi-
tized and challenged. The RSS group was mock-allergen
sensitized and challenged and RSV-infected at 21 d of age.
The ROO group was Ova sensitized and challenged and
subsequently RSV-infected at 21 d of age. The SSR group
was mock-allergen sensitized and challenged and subse-
quently RSV-infected at 47 d of age. The OOR group was
Ova sensitized and challenged and subsequently RSV-
infected at 47 d of age. Three mice in each group were sac-
rificed four days post-infection to assess pulmonary viral
titers as described above. Assessment of airway reactivity
and collection of tissue and BAL samples, as detailed
below, were performed on protocol day 34 (55 days of age
and 8 days following RSV infection).
Assessment of Airway Reactivity in Response to 
Methacholine
Whole body plethysmography
Airway responsiveness to methacholine (MeCh), a mus-
carinic agonist, was assessed by whole body plethysmog-
raphy (Buxco Electronics, Troy, NY and EMKA
Technologies, Falls Church, VA) as described previ-
ously[19]. Mice were exposed for 3 minutes to aerosolized
saline and subsequently to increasing concentrations of
aerosolized MeCh (0, 3.125, 6.25, 12.5, 25, and 50 mg/ml
in isotonic saline; Sigma). Following each nebulization,
data including minute volume, tidal volume, breathing
frequency, and enhanced paused (Penh) were recorded
for 3 minutes. The Penh values measured during each 3-
minute sequence were averaged and expressed for each
dose of MeCh. Baseline Penh values did not differ signifi-
cantly between any of the groups.
Invasive measurements of respiratory mechanics
Pulmonary resistance was measured using the forced
oscillation technique as previously described[20]. Anes-
thetized animals were mechanically ventilated with a tidal
volume of 10 ml/kg and a frequency of 2.5 Hz using a
computer-controlled piston ventilator (Flexivent,
SCIREQ; Montreal, Canada). Responses were determined
in response to increasing concentrations of aerosolized
MeCh (0, 1.875, 3.75, 7.5, 15, and 30 mg/ml in isotonic
saline). All data that did not result in a coefficient of deter-
mination that was greater than 0.9 were excluded. The
average value for each dose was calculated; and the per-
cent difference from baseline per dose was then plotted.
Sample Collection
On protocol day 34, all mice were euthanized and the fol-
lowing samples were obtained:
Lavage fluid
Bronchoalveolar lavage (BAL) of the lungs was performed
using 1 ml of PBS containing 2% FBS. Total BAL cellularity
was determined with the use of a hemocytometer. Cyt-
ospin slides were fixed and stained using the Diff-Quick
kit (IMEB, Chicago, IL) and differential cell counts by
unbiased observers were based on counts of 200–300 cells
using standard morphological criteria to classify individ-
ual leukocyte populations. Four mice from each group
were used for these analyses.
Schematic of study protocol and exposure groups Figure 1
Schematic of study protocol and exposure groups. 
Weanling mice (21 days of age) were injected i.p. with oval-
bumin complexed to Imject Alum (Ova, ROO, and OOR 
groups) or with isotonic saline (Sal, RSS, and SSR groups) on 
protocol days 0 and 14. After 1 h, the ROO and RSS groups 
were infected with RSV (104 TCID50/g body weight). These 
mice were then exposed to aerosolized ovalbumin or saline 
for 20 minutes on protocol days 24, 25, and 26. On protocol 
day 26, a subset of Sal and Ova mice were infected with RSV 
at 104 TCID50/g body weight (SSR and OOR groups, respec-
tively).Respiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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Pulmonary histology
Lungs were inflated with 1 ml of 10% neutral-buffered
formalin via a tracheostomy tube. After instillation of fix-
ative, the trachea was ligated, and the lung was excised
and fixed in formalin for 24 hours at 4°C. These tissues
were then embedded in paraffin, cut in 4 µm frontal sec-
tions, mounted onto slides, and stained with either hema-
toxylin and eosin (H&E), periodic acid-Schiff (PAS) to
quantitate mucus, Masson's trichrome (MT) to quantitate
airway collagen deposition, toludine blue to quantitate
mast cells, or anti-MBP (major basic protein) antibodies
to specifically evaluate tissue-infiltrating eosinophils as
previously described[21]
Morphometric analyses
The MT data were analyzed morphometrically by digital
image analysis using Image-Pro Plus software (version
5.0.1, Media Cybermetics, Inc., Silver Spring, MD). The
following calculation was used to determine airway
mucus: % airway mucus = (the area of airway epithelium
staining positive for mucus/the total area of airway epithe-
lium) × 100. To calculate the thickness of collagen depo-
sition within the basement membranes, a random starting
point was chosen and a single measurement was made
between two points on either side of the collagen deposi-
tion at right angles to a tangent marking the perimeter of
the basement membrane. For each airway, measurements
at approximately 50 µm intervals from a randomly chosen
starting point were made around the entire airway. The
measured values were averaged for the airways of each
animal and the mean values for each group were deter-
mined.
Cytokine Assays
Cytokine levels in whole lung homogenates were deter-
mined using the Mouse Th1/Th2 Cytokine Cytometric
Bead Array Kit (BD Biosciences) as per the manufacturer's
instructions. The sensitivity of the assay was as follows:
TNF-α – 6.3 pg/ml, INF-γ – 2.5 pg/ml, and IL-5, IL-4 and
IL-2 – 5 pg/ml. The data was resolved in the FL3 channel
and acquired with a BD FACScan™ flow cytometer. Data
analyses were performed using the BD Cytometric Bead
Array Software to generate standard curves for each
cytokine and to determine sample cytokine levels.
Statistical Analysis
Data are presented as mean ± SEM obtained from experi-
ments with n = 8 for whole body plethysmography analy-
sis of AHR, n = 4 for invasive measurements of pulmonary
mechanics, pulmonary viral titers, and histology, n = 3 for
cytokine assays. For AHR and BAL cellularity, differences
between groups were evaluated by means of two-way
ANOVA. Bonferroni post-tests were performed to com-
pare between pairs of groups. To determine statistical sig-
nificance of the morphometric data, we employed a
Kruskal-Wallis test with a Dunn's post-test. A one-way
ANOVA was used to compare the mean cytokine levels
among the various groups followed by the Tukey-Kramer
multiple comparisons tests for significance between the
groups. This was repeated for each individual cytokine.
Differences between means were considered significant
when p < 0.05.
Results
AHR is Enhanced in Weanling Mice Exposed First to Ova 
then Infected with RSV
In order to investigate the role of RSV infection in relation
to other environmental factors such as allergen, we sensi-
tized and challenged weanling mice with Ova as shown in
Figure 1. One hour post-sensitization, a subset of mice
was infected with RSV (104 TCID50/g body weight). On
the last day of allergen challenge, another subset of mice
was infected with RSV. Eight days following the last Ova
challenge, mice were exposed to increasing doses of MeCh
and AHR was assayed. As shown in Figure 2A, RSV infec-
tion before (RSS) or after (SSR) saline administration
failed to alter AHR. However, weanling mice exposed to
Ova and then RSV (OOR) had significantly greater airway
hyperresponsiveness to MeCh compared to all other
groups (p < 0.001). AHR of weanling mice exposed first to
RSV and then Ova (ROO) was similar to that of mice
exposed only to Ova (OVA).
The consequences of altered airway responsiveness were
further examined in vivo by invasive measurements of air-
way resistance. Respiratory system mechanics were
assessed using the single-compartment model. The lung
mechanics of weanling mice exposed to Ova and RSV
(OOR) were significantly elevated as compared to control
mice in response to MeCh administration (Figure 2B; p <
0.001).
Allergen Sensitization and Challenge Decreases Pulmonary 
RSV Titer
Four days post-infection, we assessed pulmonary viral tit-
ers for all groups of mice. As expected, mice from the OVA
and SAL groups displayed no evidence of viral replication.
The mean viral titer in the lungs of weanling mice exposed
to RSV alone (RSS) was 3.2 ± 0.08 log10 TCID50/g of lung,
while viral titers in adult mice exposed to RSV (SSR) were
5.3 ± 0.1 log10 TCID50/g. Intriguingly, the reverse was true
for mice infected with RSV in the presence of allergen sen-
sitization. If mice were infected with RSV prior to Ova sen-
sitization and challenge (ROO), then viral titers were high
(5.2 ± 0.08 log10 TCID50/g); however if mice were sensi-
tized and challenged with Ova prior to RSV infection
(OOR) then the resulting viral titer (3.2 ± 0.2 log10
TCID50/g) was significantly lower (p < 0.001).Respiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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BAL Cellularity Increases in Mice Exposed to Ova and RSV
To evaluate the pulmonary immune response to RSV and
Ova exposure, BAL fluid cells were recovered, and the total
cellularity and composition of leukocytes among the
groups of animals were compared. Total cell counts from
the BAL fluid of the SAL, OVA, RSS, and SSR groups were
not significantly different as shown in Figure 3. However,
total cell counts from the BAL fluid of mice exposed to
both RSV and Ova (ROO and OOR) were significantly
greater than any other group (7.73 × 105 ± 0.19 and 4.65
× 105 ± 0.25; respectively). A comparison of individual
cell numbers per ml of BAL fluid reveals that these
increases were mainly due to increases in eosinophil and
lymphocyte cell populations. To compare cell propor-
tions among the different exposure groups, BAL cellulari-
ties were expressed as the product of the total number of
cells recovered and the percentages of each cell type
derived from differentials. RSV infection, in the presence
of allergen challenge, led to a significant increase in total
BAL cellularity (ROO and OOR). Interestingly, this
increase was highest in the group of mice that were
infected prior to allergen challenge (ROO). A significant
reduction in the number of BAL macrophages was
observed in the OVA, SSR, and OOR groups. Eosinophilia
was observed only in the groups that received Ova (OVA,
ROO, and OOR groups; p < 0.001). No significant differ-
ence in neutrophil numbers was observed in any of the
groups.
Enhanced Pulmonary Pathology is Observed in Weanling 
Mice Exposed to Ova and Subsequently Infected with RSV
The pulmonary histology induced by allergic sensitization
and RSV infection is illustrated in Figure 4. Weanling mice
exposed to Ova followed by infection with RSV (OOR)
exhibited a significantly greater degree of pulmonary
inflammation in both the peribronchial and perivascular
regions (Figure 4, panel A). Additional histological analy-
ses of the lungs of OOR mice demonstrated that other
Enhanced airway hyperreactivity and pulmonary resistance in weanling mice exposed to RSV and OVA Figure 2
Enhanced airway hyperreactivity and pulmonary resistance in weanling mice exposed to RSV and OVA. A) Air-
way hyperreactivity (Penh) of each group is plotted as a function of increasing doses of inhaled MeCh. Data points are mean ± 
SEM from 8–10 mice per group. Groups as outlined in Figure 1. B) Lung resistance values were obtained by a forced oscillation 
technique and are plotted as a function of increasing doses of inhaled MeCh. Values presented are means ± SEM (n = 4 mice/
group). *p < 0.001 for OOR vs. all other groups.Respiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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changes were present. Lung sections stained with PAS to
detect mucus showed a significant increase in mucus pro-
duction and mucus cell hypertrophy (Figure 4, panel B).
Morphometric analyses of the PAS stained lung sections
revealed a 2.3 fold increase in the percentage of airway
mucus in the OOR group compared to the Ova group (35
± 0.4% vs. 15 ± 2.2%, respectively; p < 0.05). Immunoflu-
orescent staining using an anti-MBP antibody, which is
specific for eosinophils, demonstrated an increase in the
number of eosinophils that were associated with areas of
expanded bronchus-associated lymphoid tissue (BALT)
(Figure 4, panel C). There was no evidence of pulmonary
inflammation, eosinophilia, or mucus production in the
SAL, RSS, or SSR groups. In addition, no significant
recruitment (i.e., average of 2 per entire lung section) of
mast cells was observed in any of the exposure groups.
Visual analysis of the OOR lung sections indicated thick-
ening of the subepithelial reticular layer indicative of air-
way remodeling. To investigate the role of airway
remodeling in the enhanced pulmonary pathophysiology
observed in these groups lung sections were stained with
Masson's trichrome. All groups exposed to Ova (OVA,
ROO, and OOR) displayed an increase in subepithelial
fibrosis that was accompanied by an increase in airway
collagen deposition compared to the SAL control group
(Figure 5). In fact, a two-fold increase in the amount of
basement membrane associated-collagen was observed in
the OOR group relative to Ova alone (8.3 ± 0.9 µm vs. 4.2
± 0.4 µm; p < 0.01). Neither group exposed to RSV alone
(RSS and SSR) developed observable airway pathologies.
Allergen Sensitization of Weanling Mice and Subsequent 
Infection with RSV Increases the Levels of both Th1 and 
Th2 Cytokines
To determine how exposure of weanling mice to Ova and
RSV enhanced AHR and led to pulmonary fibrosis, the
concentration of various cytokines in whole lung
homogenates was measured. When lung homogenates
were isolated on the final day of the protocol (i.e., day
34), no significant difference in cytokine levels for TNF-α,
IFN-γ, IL-5, IL-4, or IL-2 were observed. In standard Ova
models demonstrating allergic inflammation and AHR,
expression of Th2 cytokines such as IL-4 and IL-13 typi-
cally peak within 48 hours of final allergen challenge and
in most cases return to baseline levels within 96
hours[20,22-24]. Therefore, these studies were repeated
using whole lung homogenates that were isolated 4 days
post infection (i.e., protocol day 4 for the ROO group and
day 30 for the OOR group). Cytokine levels from the ROO
group were not significantly different from the OVA or
SAL groups (data not shown). Interestingly, significantly
elevated levels of TNF-α, IFN-γ, IL-5, and IL-2 were
observed in the OOR group (151 ± 20 pg/ml, 3663 ± 121
pg/ml, 58 ± 7.5 pg/ml, 34 ± 6.2 pg/ml; respectively) as
compared to the OVA group (15 ± 3.4 pg/ml, 7.4 ± 0.12
pg/ml, 10 ± 0.97 pg/ml, 13 ± 1.9 pg/ml; respectively) (Fig-
ure 6). Levels of IL-4 in the OOR group were similar to
that of the OVA group (24 ± 1.9 pg/ml vs. 16 ± 2.7 pg/ml,
respectively).
Discussion
In the present study, we have shown that exposure of
weanling mice to RSV followed by Ova does not lead to
(AHR) or pulmonary pathologies greater than that
induced by Ova sensitization and challenge alone. In con-
trast, exposure of weanling mice to Ova followed by RSV
infection leads to long-term pulmonary consequences at
the pathophysiological level. RSV infection of weanling
mice (unless accompanied by Ova sensitization and chal-
lenge) was unable to induce significant histopathologies
or AHR. However, early sensitization and challenge with
Ova followed by infection with RSV induced a 2.6 fold
increase in AHR over SAL controls and a 2 fold increase
over Ova alone (Figure 2A). The enhanced AHR coincided
with increased: 1) total BAL cellularity (increases were
specifically observed in eosinophil and lymphocyte cell
numbers); 2) pulmonary inflammation in both the
perivascular and peribronchial regions of the lungs; 3)
mucus cell hypertrophy and airway mucus production; 4)
elevated levels of TNF-α, IFN-γ, IL-5, and IL-2 and airway
collagen deposition; and 5) subepithelial fibrosis. These
BAL fluid cellularity is altered in mice exposed to RSV and/or  OVA Figure 3
BAL fluid cellularity is altered in mice exposed to 
RSV and/or OVA. Differential cell counts were performed 
on Diff-quick stained cytospin preparations by two unbiased 
observers counting > 300 cells per sample. BAL cellularities 
are expressed as the product of the total number of cells 
recovered and the percentages of each cell type derived 
from differentials. Data are expressed as means ± SEM.Respiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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data suggest that pulmonary remodeling events are occur-
ring in weanling mice exposed to allergen followed by
RSV infections and, furthermore, that these exposures syn-
ergistically enhance pulmonary pathology and physiol-
ogy. In fact, preliminary data suggest that AHR is
prolonged only in the OOR group (> 4 weeks post infec-
tion), whereas AHR in the OVA and ROO groups was no
longer significantly different from SAL controls forty-eight
hours after the last allergen challenge.
Rarely, in humans or mice, is eosinophilia associated with
primary RSV infection. However, RSV infection in combi-
nation with Ova sensitization and challenge resulted in
significant pulmonary eosinophilia in both the pulmo-
nary tissue and BAL fluid (OVA: 1.3 × 105 ± 0.1; ROO: 2.3
× 105 ± 0.3; and OOR: 1.8 × 105 ± 0.2). These results seem
inconsistent with those of Peebles et al. [25], who
reported decreases in allergen-induced pulmonary eosi-
nophilia when RSV infection preceded allergen challenge.
Although the exact cause for this discrepancy is unknown,
there are several methodological differences between our
studies, which may be pertinent. Peebles and colleagues:
1) used adult mice in their studies, 2) exposed their mice
to daily Ova aerosol challenges for eight days, and 3)
infected their mice 14 days post Ova challenge. Whereas
we: 1) used weanling mice, 2) exposed mice to aero-
solized Ova for 20 min for three consecutive days, and 3)
infected our mice prior to Ova sensitization (ROO) or
Enhanced pulmonary histopathology is observed in mice exposed to Ova and RSV Figure 4
Enhanced pulmonary histopathology is observed in mice exposed to Ova and RSV. Lung sections from formalin-
fixed, paraffin-embedded tissue were stained for A) cellularity, B) mucus (purple), and C) eosinophils (green) as described in 
the materials and methods section. The photographs are representative of the staining that occurs in the bronchioles of SAL, 
OVA, SSR, and OOR exposed mice. Although not shown, the RSS resembled the SSR group and the ROO group was not sig-
nificantly different from the OVA mice. Scale bar = 50 µm.Respiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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immediately following the last Ova challenge (OOR).
Although the enhanced recruitment of any one cell did
not correlate with pulmonary pathologies, the ratio of
total macrophages to eosinophils in the BAL fluid corre-
lated fairly well with pathophysiology (OVA: 0.3 vs. OOR:
0.4).
Culley and colleagues in their neonatal model of RSV
infection [13] demonstrated that RSV infection of young
mice (0–14 d of age) produced more severe disease ini-
tially and upon subsequent rechallenge than did infection
of adult mice. In fact, the younger the mouse upon initial
RSV infection, the stronger the Th2 polarized immune
response to RSV upon secondary infection. Furthermore,
human data suggested a link between RSV lower respira-
tory tract infections in infancy and the later development
of asthma [5-10]. Thus, we were expecting to see pulmo-
nary changes in weanling mice (21 d of age) exposed to
RSV alone (RSS). However, we failed to see any patho-
physiological response to RSV alone (RSS and SSR) or to
weanling exposure to RSV followed by allergen (ROO).
Although this data was unexpected, we feel that it further
supports Culley's original work[13] and the more recent
work of Dakhama and colleagues[14] demonstrating the
importance of timing of the initial exposure to RSV.
Although not presented here, we have preliminary data
suggesting that earlier infection with RSV during neonatal
development (7 d of age) is sufficient to induce long-term
functional consequences in the mouse even in the absence
of allergic inflammation. In summary, the age of primary
RSV infection has a crucial role in determining disease
outcome and suggests that immunity in weanling mice
may have matured beyond the polarized Th2 responses of
the neonate.
Histological analyses of weanling mice first exposed to
Ova and then infected with RSV (OOR group) revealed
changes consistent with airway remodeling including sub-
epithelial fibrosis, collagen deposition, smooth muscle
hypertrophy, and mucus cell hyperplasia. Histological
changes observed in the ROO group were similar to mice
receiving Ova alone (OVA group). The amount of airway
remodeling observed was positively correlated with
increased airway hyperresponsiveness to aerosolized
MeCh and with macrophage/eosinophil ratios in the OVA
and OOR groups. Our data (presented here and else-
where[20]) along with the data of others[26] suggest that
eosinophils play a prominent role in orchestrating the
local pulmonary immune responses and pathologies
associated with allergic inflammation (i.e., asthma). It
will be interesting to see if the specific loss of eosinophils
leads to improvement of pulmonary function parameters
and pathologies associated with neonatal RSV infection.
Analysis of cytokine data demonstrated elevations in both
Th2 and Th1 cytokines. Previous studies have clearly dem-
onstrated that TNF-α contributes to early clearance of RSV
[27]; however, continued production of TNF-α exacer-
bates RSV-induced illness [28]. Furthermore, neutraliza-
tion of TNF-α has been shown to reduce clinical illness
without an impairment on viral clearance[29]. Interest-
ingly, the OOR group exhibited greater than 10 times the
amount of TNF-α observed in any other group. One might
also argue that IFN-γ expression in the OOR group, which
is upregulated almost 500 fold over the OVA group, is
important in the physiologic and histologic injury
observed in the OOR group. However, TNF-α levels were
still detectable at 17.2 ± 2.4 pg/ml long after (i.e., 8 days)
IFN-γ expression was no longer detectable. Though the
mechanisms are unclear, the data presented here suggest
that the extended upregulation of TNF-α may be impor-
tant in the lung injury and remodeling events observed in
the OOR group.
Interestingly, pulmonary viral titers appeared to be
dependent on age at initial RSV infection and allergic phe-
Airway remodelling is evident in weanling mice exposed to  Ova and RSV Figure 5
Airway remodelling is evident in weanling mice 
exposed to Ova and RSV. Fibrosis and deposition of colla-
gen was observed in the subepithelial, reticular layer of the 
airways in the OVA, ROO, and OOR mice. Morphometric 
analyses using data collected at 50 µm intervals over the 
entire basement membrane revealed that these differences 
were significant. (8–10 measurements at ~50 µm intervals 
were collected for at least 5 airways; n = 4 mice per group). 
ROO vs. OOR, *p < 0.05 and OVA vs. OOR, *p < 0.01.Respiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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notype of the mice. Recall that the RSS and OOR groups
had significantly lower viral titers than the ROO and SSR
groups. We believe that low RSV titers in the RSS group are
the result of the Th2-bias that is known to occur in the
early neonatal immune system of both mice and humans
[30-32], while the low RSV titers in the OOR group are the
result of Ova-induced Th2 immune responses. Further-
more, our previous studies demonstrated that eosinophil
associated ribonuclease 11 (Ear11) transcripts increase in
response to Th2 inflammatory events, such as Ova sensiti-
zation and challenge, and that this increase is paralleled
by a concomitant increase in RNase activity in the BAL
fluid[18]. Ear11 belongs to a family of eosinophil associ-
ated RNases, including eosinophil-derived neurotoxin
(EDN) and eosinophil cationic protein (ECP). Both EDN
and ECP have been shown to possess antiviral activities
against a range of single-stranded RNA viruses including
RSV [33-35]. Thus, these data cumulatively suggest that
the expression of Ear11 in response to a Th2 environment
provides the protective (i.e., antiviral) effects observed in
the RSS and OOR groups. Ongoing studies in this labora-
tory with Ear11 depletion strategies are expected to
resolve this question.
Severe RSV infections (i.e., requiring hospitalization) dur-
ing infancy are associated with the development of subse-
quent wheeze and pulmonary dysfunction including a
diagnosis of asthma in later life [6,11,12,36-41]. One
hypothesis is that RSV bronchiolitis is simply more severe
in atopic individuals. In fact, our studies demonstrated
that interactions between RSV infection and allergen-
induced immune responses exacerbate pulmonary
inflammation and airway physiology. Furthermore, the
synergism between RSV and allergen leads to long-term
pulmonary consequences such as airway remodeling and
may explain progressive lung disease in humans. An alter-
native hypothesis is that severe RSV infections during
infancy are a predisposing factor for the development of
airway inflammatory disease states, such as asthma. In
this scenario, RSV infection during infancy, when the
immune system is still developing and is in a Th2-skewed
state, initiates a Th2 polarized primary immune response
and subsequently a Th2 polarized memory response to
RSV [41]. Such a response may even be heightened in
atopic individuals. Although compelling evidence in sup-
port of the later hypothesis comes from recently pub-
lished data [13], we did not find evidence of this in our
studies using weanling mice. It is important to point out
that this may be due entirely to age at primary infection,
since data from other labs[13,14] and unpublished data
from our laboratory demonstrate that infections at earlier
time points (i.e., 7 days post-partum) leads to long-term
immune and pulmonary consequences for the host.
Respiratory tract viral infections account for approxi-
mately 85% of asthma exacerbations in children, and
80% of those children have allergic
asthma[11,38,39,42,43]; therefore, it is imperative that
we understand the mechanisms by which viral infections
lead to asthma exacerbations. Although it remains unclear
what is responsible for RSV-enhanced allergic inflamma-
tion in the lung, what is obvious is that AHR in RSV and
Ova exposed mice does not correlate with RSV titer. In
contrast, AHR does appear to correlate with increased pul-
monary eosinophilia, lymphocyte cell numbers, a
decrease in macrophage numbers, and most importantly
pulmonary remodeling. Our data suggest that exposure to
allergens and RSV leads to increased structural changes in
the conducting airways. And it is these structural changes
in the developing lung that may be ultimately responsible
for the progressive development of the chronic inflamma-
tory disease state known as adult asthma.
Conclusion
Weanling mice exposed to allergen and RSV exhibit
enhanced immune cell responses, which are accompanied
by long-term changes in airway structure and function.
Although this increased pathologic response was associ-
ated with RSV infection, the enhanced pathologies were
not dependent upon pulmonary viral titer. Airway remod-
eling was evident in the lungs of adult mice exposed to
RSV and Ova and may provide an explanation for obser-
vations suggesting that viral exacerbations of asthma have
long-term physiological consequences. Airway remode-
Th1 and Th2 cytokine levels are elevated in the lungs of  OOR mice Figure 6
Th1 and Th2 cytokine levels are elevated in the lungs 
of OOR mice. CBA analysis was used to determine the 
concentration of TNF-α, IFN-γ, IL-5, IL-4, and IL-2 in whole 
lung homogenates (n = 3 mice per group; *p < 0.01) isolated 
on protocol day 30. Data are expressed as means ± SEM.Respiratory Research 2005, 6:122 http://respiratory-research.com/content/6/1/122
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ling was correlated with elevated levels of TNF-α in the
lungs. Extrapolation of these studies to exposures occur-
ring in human neonates highlights the importance of pre-
ventative strategies against RSV infection of atopic
individuals during neonatal development.
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